e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Beta-blockers may now be beneficial in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Beta-blocker-induced asthma
J. Lammers (Utrecht, Netherlands)
Source:
Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Session:
Beta-blockers may now be beneficial in asthma and COPD
Session type:
Hot topics
Number:
4602
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lammers (Utrecht, Netherlands). Beta-blocker-induced asthma. Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma
Source: Eur Respir J 2002; 19: 846-852
Year: 2002
COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Psychologicl distress in asthma and COPD
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012
Noneosinophilic asthma
Source: Eur Respir J 2003; 22: 188-189
Year: 2003
Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
Source: Eur Respir J 2010; 36: 494-502
Year: 2010
Circumstances of hospital deaths of asthma and /or COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 238s
Year: 2003
Exacerbations of asthma and COPD
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Exacerbations of asthma and COPD
Source: ERS Skills Course 2016
Year: 2016
Exacerbations of asthma and COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Comorbidities in severe asthma
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019
Overdiagnosis of COPD and asthma among elderly with chronic dyspnea
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
Hospitalisation for RSV bronchiolitis and the risk of wheezing disorders and atopy
Source: ISSN=ISSN 1810-6838, ISBN=, page=171
Year: 2005
Difficult-to-treat and severe asthma
Source: Breathe 2014; 10: 91-94
Year: 2014
Not all who wheeze have asthma
Source: Breathe 2010; 7: 16-22
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept